INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

The detection and study of patient with high blood pressure

Enciso-Muñoz, José Manuel; Olvera-Ruiz, Rafael; Patiño-Llamas, Alfredo Manuel

ABSTRACT

High blood pressure (HBP) is the most important cardiovascular risk factor for cardiovascular disease. Patients with uncomplicated HBP without target organ damage are usually asymptomatic. This leads to significant underdiagnosis of HBP, which contributes to a great extent to the poor control of the hypertensive population, which increases likelihood for complications. In this review, we summarize the clinical presentation of HBP, as well as the role of physical examination, laboratory, and complementary studies as well as the impact of these in the diagnosis of HBP. We also assess the role of HBP in mediating cardiovascular risk, cardiovascular outcomes and pathophysiological changes which lead to impaired vascular and cardiovascular function in patients living with HBP.
  FULL TEXT PDF  

Keywords

High blood pressure paraclinical studies in high blood pressure cardiovascular risk




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Statement from the Presidency of ANCAM and its Editorial Committee
    2025, Vol.36, Núm. 1
  • Leptin: a description of its intriguing biology. A review. Part I
    2025, Vol.36, Núm. 1
  • Metformin in the management of non-alcoholic fatty liver disease: current...
    2025, Vol.36, Núm. 1
  • Prophylactic use of intravascular balloon occlusion in elective general...
    2025, Vol.36, Núm. 1
  • Observational Registry for Cardiac Ablation in Atrial Fibrillation in Mexico...
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/